Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $66.4B |
| FY2017, ended Dec 31, 2017 | $99.7B |
| FY2018, ended Dec 31, 2018 | $127B |
| FY2019, ended Dec 31, 2019 | $153B |
| FY2020, ended Dec 31, 2020 | $194B |
| FY2021, ended Dec 31, 2021 | $248B |
| FY2022, ended Dec 31, 2022 | $191B |
| FY2023, ended Dec 31, 2023 | $191B |
| FY2024, ended Dec 31, 2024 | $196B |
| FY2025, ended Dec 31, 2025 | $218B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $179B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $20.9B |
| FY2017, ended Dec 31, 2017 | $27.4B |
| FY2018, ended Dec 31, 2018 | $30.6B |
| FY2019, ended Dec 31, 2019 | $31.9B |
| FY2020, ended Dec 31, 2020 | $34.6B |
| FY2021, ended Dec 31, 2021 | $43.1B |
| FY2022, ended Dec 31, 2022 | $43.7B |
| FY2023, ended Dec 31, 2023 | $40.1B |
| FY2024, ended Dec 31, 2024 | $42.0B |
| FY2025, ended Dec 31, 2025 | $44.3B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $45.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.40B | $2.08B |
| FY2017, ended Dec 31, 2017 | $477M | $4.43B |
| FY2018, ended Dec 31, 2018 | $2.37B | $4.91B |
| FY2019, ended Dec 31, 2019 | $3.69B | $4.50B |
| FY2020, ended Dec 31, 2020 | $4.50B | $5.72B |
| FY2021, ended Dec 31, 2021 | $7.07B | $8.65B |
| FY2022, ended Dec 31, 2022 | $6.93B | $7.80B |
| FY2023, ended Dec 31, 2023 | $5.72B | $5.06B |
| FY2024, ended Dec 31, 2024 | $13.4B | $6.35B |
| FY2025, ended Dec 31, 2025 | $6.52B | $7.39B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $6.28B | $7.38B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $18.6B |
| FY2017, ended Dec 31, 2017 | $9.41B |
| FY2018, ended Dec 31, 2018 | $3.84B |
| FY2019, ended Dec 31, 2019 | $3.86B |
| FY2020, ended Dec 31, 2020 | $6.84B |
| FY2021, ended Dec 31, 2021 | $9.80B |
| FY2022, ended Dec 31, 2022 | $9.88B |
| FY2023, ended Dec 31, 2023 | $6.90B |
| FY2024, ended Dec 31, 2024 | $7.62B |
| FY2025, ended Dec 31, 2025 | $8.52B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $6.80B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $22.0B |
| FY2017, ended Dec 31, 2017 | $27.9B |
| FY2018, ended Dec 31, 2018 | $19.6B |
| FY2019, ended Dec 31, 2019 | $18.1B |
| FY2020, ended Dec 31, 2020 | $18.7B |
| FY2021, ended Dec 31, 2021 | $18.1B |
| FY2022, ended Dec 31, 2022 | $16.8B |
| FY2023, ended Dec 31, 2023 | $14.7B |
| FY2024, ended Dec 31, 2024 | $14.1B |
| FY2025, ended Dec 31, 2025 | $12.9B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $34.0B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 0.8% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.73B |
| FY2017, ended Dec 31, 2017 | 1.75B |
| FY2018, ended Dec 31, 2018 | 1.76B |
| FY2019, ended Dec 31, 2019 | 1.76B |
| FY2020, ended Dec 31, 2020 | 1.77B |
| FY2021, ended Dec 31, 2021 | 1.76B |
| FY2022, ended Dec 31, 2022 | 1.74B |
| FY2023, ended Dec 31, 2023 | 1.74B |
| FY2024, ended Dec 31, 2024 | 1.73B |
| FY2025, ended Dec 31, 2025 | 1.74B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | 1.74B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $522M | $310M |
| FY2017, ended Dec 31, 2017 | $117M | $406M |
| FY2018, ended Dec 31, 2018 | $238M | $477M |
| FY2019, ended Dec 31, 2019 | $718M | $519M |
| FY2020, ended Dec 31, 2020 | $403M | $546M |
| FY2021, ended Dec 31, 2021 | $2.30B | $640M |
| FY2022, ended Dec 31, 2022 | $3.79B | $685M |
| FY2023, ended Dec 31, 2023 | $1.23B | $644M |
| FY2024, ended Dec 31, 2024 | $1.29B | $673M |
| FY2025, ended Dec 31, 2025 | $893M | $664M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $793M | $692M |
Valuation
At current price- Market Cap
- $180B
- P/E
- 28.6×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.0×
- Price / Book
- 3.4×
- EV / EBITDA
- 19.0×
Growth
Trailing 12 months- Revenue (TTM)
- $45.1B
- Revenue Growth YoY
- 6.6%
- Revenue CAGR 3Y
- 0.5%
- Revenue CAGR 5Y
- 5.1%
- EPS Growth YoY
- −53.6%
- Net Income Growth YoY
- −53.5%
Profitability
Trailing 12 months- Gross Margin
- 56.3%
- Operating Margin
- 17.1%
- Net Margin
- 13.9%
- FCF Margin
- 16.3%
- Return on Equity
- 12.4%
Earnings
Trailing 12 months- Net Income
- $6.28B
- EPS (diluted)
- $3.57
- EBITDA
- $10.9B
- Operating Income
- $7.71B
Balance Sheet
As of Mar 31, 2026- Cash and cash equivalents
- $6.80B
- Total Debt
- $34.0B
- Net Debt
- $27.2B
- Total Assets
- $110B
- Total Liabilities
- $57.7B
- Shareholders' Equity
- $52.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $9.46B
- Capital Expenditure
- $2.09B
- Free Cash Flow
- $7.38B
Dividends and risk
Last 12 months- Dividend Yield
- 2.4%
- Dividend / Share
- $2.52
- Beta (5Y)
- 0.59
Every ratio is calculated from the company’s reported figures.